九洲药业：关于全资子公司获得药品注册证书的公告

Core Viewpoint - Jiuzhou Pharmaceutical announced the approval of its subsidiary Jiuzhou Biopharmaceutical (Taizhou) Co., Ltd. for the registration of Tofacitinib Tablets by the National Medical Products Administration [1] Company Summary - Jiuzhou Pharmaceutical's subsidiary received the drug registration certificate for Tofacitinib Tablets, previously known as Zhejiang Siwei Pharmaceutical Technology Co., Ltd. [1]